Okairos
Basel
About Okairos
Okairos AG, a bio-pharmaceutical company, focuses on the discovery and development of genetic T-cell vaccines, including hepatitis C virus. The company also provides health and allied services. It has operations in Rome and Naples, Italy. The company is based in Basel, Switzerland. Okairos AG was former subsidiary of Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $30.1M
- Funding stage: M&A
- Last round: Series B (Sep 2010)
- Website: okairos.com
- Phone: 41 61 270 35 35
Industries & Categories
Biopharma, Biotechnology, Genetics, Health Care, Medical
Canonical: https://fsome.com/organization/okairos-2433028 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.